BCM
MBOT icon

Bridgeway Capital Management’s Microbot Medical MBOT Stock Holding History

Bridgeway Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Sell
94,300
-16,700
-15% -$37.3K ﹤0.01% 1005
2025
Q4 		$222K Buy
+111,000
New +$263K ﹤0.01% 997

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Bridgeway Capital Management's MBOT Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Microbot Medical (MBOT) stake by 15% in Q1 2026, selling an estimated $37.3K and leaving 94,300 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Bridgeway Capital Management first reported a position in MBOT in Q4 2025 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Bridgeway Capital Management held 94,300 shares of Microbot Medical worth $227K as of Q1 2026.
  • Bridgeway Capital Management sold 16,700 Microbot Medical shares in Q1 2026, an estimated $37.3K.
  • Microbot Medical made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1005 holding.
  • Bridgeway Capital Management first reported a position in Microbot Medical in Q4 2025 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.